Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Genetics,Molecular Biology,Biochemistry
Reference10 articles.
1. Zulfiqar, B., Shelper, T. B. & Avery, V. M. Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discov. Today 22, 1516–1531 (2017).
2. Singh, P. et al. The C-terminal segment of Leishmania major HslU: Toward potential inhibitors of LmHslVU activity. Bioorg. Chem. 119, 105539 (2021).
3. Sundar, S. & Singh, A. Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther. Adv. Infect. Dis. 3, 98–109 (2016).
4. Gutierrez, V., Seabra, A. B., Reguera, R. M., Khandare, J. & Calderon, M. New approaches from nanomedicine for treating leishmaniasis. Chem. Soc. Rev. 45, 152–168 (2016).
5. Garami, A. & Ilg, T. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability. EMBO J. 20, 3657–3666 (2001).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献